Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
August 30, 2013
Synaptic protein α1-takusan mitigates amyloid-β-induced synaptic loss via interaction with tau and postsynaptic density-95 at postsynaptic sites
Nobuki Nakanishi, Scott D Ryan, Xiaofei Zhang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 8, 2026
SKYSCRAPER-02C: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Patients With Untreated Extensive-Stage Small Cell Lung Cancer in China
Shun Lu, Jian Fang, Yan Yu, et al.
Nature Communications
|
April 18, 2019
Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patients
Xu-Chao Zhang, Jun Wang, Guo-Guang Shao, et al.
Stem Cell Reports
|
August 30, 2016
Quantitative Analysis of Human Pluripotency and Neural Specification by In-Depth (Phospho)Proteomic Profiling
Ilyas Singec, Andrew M Crain, Junjie Hou, et al.
The Lancet. Oncology
|
December 25, 2025
First-line tiragolumab plus atezolizumab and chemotherapy in patients with previously untreated, locally advanced unresectable or metastatic oesophageal cancer (MORPHEUS-EC): a randomised, open-label, phase 1b/2 trial
Jong-Mu Sun, Yee Chao, Sung-Bae Kim, et al.
Nature Medicine
|
May 16, 2025
Atezolizumab plus bevacizumab and chemotherapy in metastatic nonsquamous NSCLC: the randomized double-blind phase 3 IMpower151 trial
Caicun Zhou, Xiaorong Dong, Gongyan Chen, et al.
Cell Reports
|
July 9, 2014
S-nitrosylation-mediated redox transcriptional switch modulates neurogenesis and neuronal cell death
Shu-Ichi Okamoto, Tomohiro Nakamura, Piotr Cieplak, et al.
Plos Pathogens
|
January 15, 2016
Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection Cohort
Elise Landais, Xiayu Huang, Colin Havenar-Daughton, et al.
Nature Communications
|
November 15, 2017
NitroSynapsin therapy for a mouse MEF2C haploinsufficiency model of human autism
Shichun Tu, Mohd Waseem Akhtar, Rosa Maria Escorihuela, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 7, 2023
First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker Results
Peter Schmid, Nicholas C Turner, Carlos H Barrios, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
August 30, 2013
Synaptic protein α1-takusan mitigates amyloid-β-induced synaptic loss via interaction with tau and postsynaptic density-95 at postsynaptic sites
Nobuki Nakanishi, Scott D Ryan, Xiaofei Zhang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 8, 2026
SKYSCRAPER-02C: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Patients With Untreated Extensive-Stage Small Cell Lung Cancer in China
Shun Lu, Jian Fang, Yan Yu, et al.
Nature Communications
|
April 18, 2019
Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patients
Xu-Chao Zhang, Jun Wang, Guo-Guang Shao, et al.
Stem Cell Reports
|
August 30, 2016
Quantitative Analysis of Human Pluripotency and Neural Specification by In-Depth (Phospho)Proteomic Profiling
Ilyas Singec, Andrew M Crain, Junjie Hou, et al.
The Lancet. Oncology
|
December 25, 2025
First-line tiragolumab plus atezolizumab and chemotherapy in patients with previously untreated, locally advanced unresectable or metastatic oesophageal cancer (MORPHEUS-EC): a randomised, open-label, phase 1b/2 trial
Jong-Mu Sun, Yee Chao, Sung-Bae Kim, et al.
Nature Medicine
|
May 16, 2025
Atezolizumab plus bevacizumab and chemotherapy in metastatic nonsquamous NSCLC: the randomized double-blind phase 3 IMpower151 trial
Caicun Zhou, Xiaorong Dong, Gongyan Chen, et al.
Cell Reports
|
July 9, 2014
S-nitrosylation-mediated redox transcriptional switch modulates neurogenesis and neuronal cell death
Shu-Ichi Okamoto, Tomohiro Nakamura, Piotr Cieplak, et al.
Plos Pathogens
|
January 15, 2016
Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection Cohort
Elise Landais, Xiayu Huang, Colin Havenar-Daughton, et al.
Nature Communications
|
November 15, 2017
NitroSynapsin therapy for a mouse MEF2C haploinsufficiency model of human autism
Shichun Tu, Mohd Waseem Akhtar, Rosa Maria Escorihuela, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 7, 2023
First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker Results
Peter Schmid, Nicholas C Turner, Carlos H Barrios, et al.
Page
of 2